Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2017; 24(1): 37-43


Effects of bosentan, sildenafil and their combination on T-wave amplitude and QT interval in a rat model of pulmonary hypertension

Derya Karpuz, Olgu Hallioglu, Belgin Buyukakilli, Serkan Gurgul, Bahar Tasdelen.




Abstract
Cited by 0 Articles

Aim: Although, bosentan and sildenafil have been used to treat PAH, the effect of these drugs on electrocardiographic (ECG) changes are still unclear. The aim of this study is to evaluate the effects of bosentan, sildenafil, and their combination on T-wave amplitude and QT interval in rats with monocrotaline (MCT)-induced PAH.
Materials and Methods: Saline (control) or MCT were applied to sixty-six male Wistar rats. By the development of PAH (4th week), MCT-given rats were randomized into 4 groups and were treated orally with bosentan, sildenafil and combination of sildenafil and bosentan or placebo for 3 weeks. Echocardiographic (ECHO) and ECG examinations were performed three times on baseline, 4th and 7th week.
Results: ECHO results showed that the application of MCT developed PAH in all injected rats. Usually, T-wave changes and QTc prolongation in ECG began after PAH and T-wave amplitudes, T-repolarization time as well as QTc intervals significantly increased in all groups after treatment (p

Key words: Pulmonary Arterial Hypertension; Rat Model; Sildenafil; Bosentan; Electrocardiography; Echocardiography






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.